Transcutaneous electrical spinal-cord stimulation in humans
Yury Gerasimenko, Ruslan Gorodnichev, Tatiana Moshonkina, Dimitry Sayenko, Parag Gad, V Reggie Edgerton, Yury Gerasimenko, Ruslan Gorodnichev, Tatiana Moshonkina, Dimitry Sayenko, Parag Gad, V Reggie Edgerton
Abstract
Locomotor behavior is controlled by specific neural circuits called central pattern generators primarily located at the lumbosacral spinal cord. These locomotor-related neuronal circuits have a high level of automaticity; that is, they can produce a "stepping" movement pattern also seen on electromyography (EMG) in the absence of supraspinal and/or peripheral afferent inputs. These circuits can be modulated by epidural spinal-cord stimulation and/or pharmacological intervention. Such interventions have been used to neuromodulate the neuronal circuits in patients with motor-complete spinal-cord injury (SCI) to facilitate postural and locomotor adjustments and to regain voluntary motor control. Here, we describe a novel non-invasive stimulation strategy of painless transcutaneous electrical enabling motor control (pcEmc) to neuromodulate the physiological state of the spinal cord. The technique can facilitate a stepping performance in non-injured subjects with legs placed in a gravity-neutral position. The stepping movements were induced more effectively with multi-site than single-site spinal-cord stimulation. From these results, a multielectrode surface array technology was developed. Our preliminary data indicate that use of the multielectrode surface array can fine-tune the control of the locomotor behavior. As well, the pcEmc strategy combined with exoskeleton technology is effective for improving motor function in paralyzed patients with SCI. The potential impact of using pcEmc to neuromodulate the spinal circuitry has significant implications for furthering our understanding of the mechanisms controlling locomotion and for rehabilitating sensorimotor function even after severe SCI.
Keywords: Neural plasticity; Neuromodulation; Painless transcutaneous electrical enabling motor control (pcEmc); Recovery; Spinal-cord injury.
Conflict of interest statement
of interest V. Reggie Edgerton and Yury Gerasimenko are shareholders in NeuroRecovery Technologies, the company providing the electric stimulator for this study. V. Reggie Edgerton is also the president and chair of the board for the company. V. Reggie Edgerton and Yury Gerasimenko hold certain inventorship rights on intellectual property licensed by The Regents of the University of California to NeuroRecovery Technologies and its subsidiaries. Ruslan Gorodnichev, Tatiana Moshonkina, Dimitry Sayenko, and Parag Gad declare that they have no conflicts of interest concerning this article.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Figures
Source: PubMed